Next Generation Cell Therapies for Cancer
Catherine Bollard, M.D., M.B.Ch.B.
Dr. Robert J. and Florence T. Bosworth Distinguished Professor of Cancer and Transplantation Biology Research
Interim Executive Vice President and Chief Academic Officer, Children's National Hospital
Director, Center for Cancer and Immunology Research
Children’s National Hospital
Interim Chair, Department of Pediatrics
Associate Dean, Pediatric Academic Affairs
The George Washington University School of Medicine and Health Sciences
Next Generation Cell Therapies for Cancer
Date: May 20, 2024
Time: 12:30 p.m.
About this Seminar
Antigen-specific T cell therapies are currently being evaluated for the treatment of cancer and viral infections. In both malignant and virus infected settings, antigen-specific T cells are pivotal for the immune system's ability to recognize and eliminate abnormal cells or pathogens while also providing long-term immunity in the host. Moreover, they can be used as a platform for gene engineering using artificial receptors such as chimeric antigen receptors (CAR). This presentation will present an overview of our work translating antigen-specific T cell therapies from the bench to the bedside for the treatment of cancer and virus associated diseases and discuss next generation cell therapies utilizing engineering strategies to overcome tumor immune evasion strategies and enhance the potency of the antigen specific T cell platform against solid tumors and blood cancers.
You May Also Be Interested In...
-
Home Item
Sudden Cardiac Arrest in the Young: The Case of ARVC , homeOct. 18, 2024, 11:00 a.m. | Mario Delmar, M.D., Ph.D., Endowed Professor of Medicine, Patricia and Robert Martinsen Professor of Cardiology, Leon H Charney Division of Cardiology, New York University School of Medicine | Pioneers in Biomedical Research Seminar, Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
-
Home Item
Harnessing Interoception: Innovative Approaches for Psychiatric Assessment and Intervention , homeOct. 25, 2024, 11:00 a.m. | Sahib Khalsa, M.D., Ph.D., Associate Professor, Louis Jolyon West Innovation Chair, Director of Anxiety Disorders Research, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles| Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home Item
Clinical Applications of Cancer Genetics , homeNov. 21, 2024, 5:30 p.m. (Reception at 5 p.m.) | Luis Diaz, Jr., M.D., Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
A Ribocentric View of Muscle Proteostasis in Health and Disease: Novel Mechanisms Potential Therapeutic Opportunities , homeNov. 22, 2024, 11:00 a.m. | Gustavo A. Nader, Ph.D., FAPS, Professor, College of Health and Human Development; Chair, Molecular, Cellular, and Integrative Physiology; Huck Institutes of the Life Sciences; The Pennsylvania State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
Human Laboratory Evaluation of Cannabis Products , homeDec. 13, 2024, 11:00 a.m. | Ryan Vandrey, Ph.D., Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Health Behaviors Research and the Addiction Recovery Research Center
-
Home Item
Mechanics of Convective Cell Motion , homeJan. 10, 2025, 11:00 a.m. | Michael Murrell, Ph.D., Associate Professor, Department of Biomedical Engineering and Physics, Yale University | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke